Sickle cell disease is treated by administering a 5-lipoxygenase inhibitor.

 
Web www.patentalert.com

< Absorbent product containing absorbent structure and bacillus coagulans

< 3-(imidazolyl)-2-alkoxypropanoic acids

> Implantable valved pressure attenuation device

> Preparation of unsaturated carboxylic acids and unsaturated carboxylic acid esters from alkanes and/or alkenes
~ 00253